News

Posted On: 01/23/2007

Vetter Launches New Ravensburg Aseptic Filling Facility

PharmaManufacturing.com

Vetter Pharma-Fertigung GmbH & Co. KG has received a manufacturing license in accordance with German Drug Law from the Tuebingen Regional Board for its new state-of-the-art plant, Ravensburg Vetter South, for aseptic filling of liquid and lyophilized drugs. After a planning and construction period of three years and an investment of 100 million euros, one of the world’s most modern production facilities is now ready to begin work. Thanks to the highest possible level of automation and an ultra-modern restricted access barrier system, Vetter can offer products of the highest quality. In addition to dual-chamber syringes and cartridges, the new location will also fill liquid or lyophilized vials, as well as single-chamber cartridges. The new, flexible production lines make it possible to change systems and formats, including line clearance, cleaning and disinfection, much more quickly than with previous design concepts. With the new facility, Vetter is broadening its portfolio of services and expanding its capacity in aseptic manufacturing by about 30 percent.

Vetter has been active as an independent pharmaceutical service partner for biotech and pharmaceutical companies for over 50 years, and began focusing on the fill and finish of liquid and lyophilized drugs about 25 years ago. Vetter Commercial Manufacturing handles the entire process, from compounds and aseptic filling to final packaging of the product.